Prednisone and Therapeutic embolisation - a phase IV clinical study of FDA data

Summary:

Therapeutic embolisation is reported as a side effect among people who take Prednisone (prednisone), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Valcyte, and have Non-hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Therapeutic embolisation when taking Prednisone. It is created by eHealthMe based on reports of 628,814 people who have side effects when taking Prednisone from the FDA, and is updated regularly.

What is Prednisone?

Prednisone has active ingredients of prednisone. It is often used in rheumatoid arthritis. eHealthMe is studying from 636,827 Prednisone users. Check the latest studies of Prednisone.

What is Therapeutic embolisation?

Therapeutic embolisation is found to be associated with 47 drugs and 161 conditions by eHealthMe. Check the latest studies of Therapeutic embolisation.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

628,814 people reported to have side effects when taking Prednisone.
Among them, 36 people (0.01%) have Therapeutic embolisation.

Could Prednisone cause Therapeutic embolisation?

Among these 36 people:

How long have people been on Prednisone when they have Therapeutic embolisation? *

What is the gender of people who have Therapeutic embolisation when taking Prednisone? *

female: 24.24 %
male: 75.76 %

What is the age of people who have Therapeutic embolisation when taking Prednisone? *

What are other drugs people take besides Prednisone? *

What are other side effects people have besides Therapeutic embolisation? *

Acute Kidney Failure: 16 people, 44.44%
Vascular Injury: 13 people, 36.11%
Haemoglobin Abnormal: 13 people, 36.11%
Pneumonia: 10 people, 27.78%
Fever: 8 people, 22.22%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 7 people, 19.44%
Haemoperitoneum (presence of blood in the peritoneal cavity): 7 people, 19.44%
Retroperitoneal Haematoma (blood clot between the peritoneum and the posterior abdominal wall): 7 people, 19.44%
Bone Marrow Disorder: 6 people, 16.67%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 6 people, 16.67%

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 13 people, 36.11%
Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer): 4 people, 11.11%
Osteoporosis (bones weak and more likely to break): 3 people, 8.33%
Interstitial Lung Disease: 2 people, 5.56%
Hypotension (abnormally low blood pressure): 2 people, 5.56%
Immunodeficiency Disorders: 2 people, 5.56%
Inflammation: 1 person, 2.78%
Bradycardia (abnormally slow heart action): 1 person, 2.78%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 2.78%
Cytomegalovirus Colitis (an inflammation of the colon from virus): 1 person, 2.78%

* Approximation only. Some reports may have incomplete information.

Do you take Prednisone and have Therapeutic embolisation?

- Check whether Therapeutic embolisation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Prednisone:

Prednisone (636,827 reports)

Browse all side effects of Prednisone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Therapeutic embolisation:

Therapeutic embolisation (47 drugs)

Browse all the conditions that are associated with Therapeutic embolisation:

Therapeutic embolisation (161 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on prednisone (the active ingredients of Prednisone) and Prednisone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.